Form 4: OptimizeRx Director Klema Reports Stock Transactions
SEC Form 4 Filing
Director Cathy Klema reports the vesting and conversion of restricted stock units into common stock of OptimizeRx Corp.
Summary
- Cathy Klema, a director of OptimizeRx Corp, filed a Form 4 detailing changes in beneficial ownership.
- On February 2, 2025, 5,109 restricted stock units vested and were converted into 5,109 shares of common stock.
- Following the transaction, Klema directly owns 11,752 shares of OptimizeRx Corp.
- The restricted stock units vested in full on February 2, 2025, the first anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by a company director, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the increase in outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/02/2025 | Date of transaction: vesting and conversion of restricted stock units. |
| 02/02/2025 | Restricted stock units vested in full, one year after the grant date. |
| 02/04/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.